Drug Combinations to Enhance Sensitivity and Circumvent Resistance

增强敏感性和规避耐药性的药物组合

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT – Administrative Core The Administrative Core will provide leadership, scientific oversight, governance, and administrative support to our Drug Combinations to Circumvent Resistance-Drug Resistance and Sensitivity Center (D2CR-DRSC) to ensure effective operations, communication, internal and external collaborations, compliance and rigorous scientific evaluation of D2CR-DRSC projects. Co-PD/Contact PI Jeffrey Tyner and Co-PD/PI Brian Druker will serve as Co-Leaders of the Administrative Core and will be supported by a Scientific Operations Leader, Cristina Tognon; a Collaborations Manager, Pierrette Lo; and a Research and Finance Administrator, Sarah Bowden. The Specific Aims of the Administrative Core are to: 1) provide scientific and administrative leadership, governance, and support to the D2CR-DRSC to ensure effective integration of all projects, evaluation of center progress, sharing of specimens and data, and internal communication and operational performance, and 2) provide scientific and administrative leadership to optimize the D2CR-DRSC’s communication and collaborations with the Drug Resistance and Sensitivity Network to ensure productive participation in cross-DRSC, NCI activities and the research community. To achieve these aims, the Administrative Core will establish and implement D2CR-DRSC governance, including establishing an Internal Advisory Group and an External Advisory Board to help evaluate the Center’s progress toward its aims and milestones; develop and follow policy to ensure timely release and sharing of specimens and data; plan regular strategic interactions and meetings; develop communications plans; ensure budget oversight and compliance; manage intellectual property issues; complete annual progress reports; facilitate communication, collaboration and data and resource sharing with the NCI, the DRSC Steering Committee, and the four other DRSCs in the Network; and perform all other administrative duties required to support the D2CR-DRSC and its successful participation in the Drug Resistance and Sensitivity Network.
项目摘要/摘要--行政核心 行政核心将提供领导、科学监督、治理和行政支持,以 我们规避耐药性的药物组合-耐药性和敏感性中心(D2CR-DRSc) 确保有效的运营、沟通、内部和外部协作、合规和严谨 对D2CR-DRSc项目进行科学评估。联合PD/联系Pi Jeffrey Tyner和Co-PD/Pi Brian Druker Will 担任行政核心的共同领导人,并将由一名科学业务负责人提供支助, Cristina Tognon;协作经理Pierrette Lo;以及研究和财务管理员Sarah 鲍登。行政核心的具体目标是:1)提供科学和行政 对D2CR-DRSC的领导、治理和支持,以确保有效整合所有项目, 评估中心进展、共享标本和数据、内部沟通和运作 性能,以及2)提供科学和管理领导,以优化D2CR-DRSC 与抗药性和敏感度网络的沟通和合作,以确保富有成效 参与跨DRSC、NCI活动和研究界。为了实现这些目标, 行政核心将建立和实施D2CR-DRSC治理,包括建立内部 咨询小组和外部咨询委员会,以帮助评估中心在实现其目标和 里程碑;制定和遵循政策,以确保及时发布和共享标本和数据;定期计划 战略互动和会议;制定沟通计划;确保预算监督和遵守; 管理知识产权问题;完成年度进度报告;促进沟通、协作 以及与NCI、DRSC指导委员会和 并履行支持D2CR-DRSC及其成功实施所需的所有其他行政职责 参与抗药性和敏感性网络。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeffrey Wallace Tyner其他文献

Jeffrey Wallace Tyner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeffrey Wallace Tyner', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10038080
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Trajectory and Architecture of Tumor Intrinsic Drug Resistance in AML
AML 肿瘤内在耐药性的轨迹和结构
  • 批准号:
    10684105
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10494402
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Trajectory and Architecture of Tumor Intrinsic Drug Resistance in AML
AML 肿瘤内在耐药性的轨迹和结构
  • 批准号:
    10517760
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10684102
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
增强敏感性和规避耐药性的药物组合
  • 批准号:
    10249170
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Drug Combinations to Enhance Sensitivity and Circumvent Resistance
增强敏感性和规避耐药性的药物组合
  • 批准号:
    9985235
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9985230
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10517758
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10249167
  • 财政年份:
    2017
  • 资助金额:
    $ 72.78万
  • 项目类别:

相似海外基金

A study for cross borders Indonesian nurses and care workers: Case of Japan-Indonesia Economic Partnership Agreement
针对跨境印度尼西亚护士和护理人员的研究:日本-印度尼西亚经济伙伴关系协定的案例
  • 批准号:
    22KJ0334
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Challenges of the Paris Agreement Exposed by the Energy Shift by External Factors: The Case of Renewable Energy Policies in Japan, the U.S., and the EU
外部因素导致的能源转移对《巴黎协定》的挑战:以日本、美国和欧盟的可再生能源政策为例
  • 批准号:
    23H00770
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
NSF-NOAA Interagency Agreement (IAA) for the Global Oscillations Network Group (GONG)
NSF-NOAA 全球振荡网络组 (GONG) 机构间协议 (IAA)
  • 批准号:
    2410236
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
    Cooperative Agreement
Conditions for U.S. Agreement on the Closure of Contested Overseas Bases: Relations of Threat, Alliance and Base Alternatives
美国关于关闭有争议的海外基地协议的条件:威胁、联盟和基地替代方案的关系
  • 批准号:
    23K18762
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
MSI Smart Manufacturing Data Hub – Open Calls Grant Funding Agreement
MSI 智能制造数据中心 – 公开征集赠款资助协议
  • 批准号:
    900240
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
    Collaborative R&D
Continuation of Cooperative Agreement between U.S. Food and Drug Administration and S.C. Department of Health and Environmental Control (DHEC) for MFRPS Maintenance.
美国食品和药物管理局与南卡罗来纳州健康与环境控制部 (DHEC) 继续签订 MFRPS 维护合作协议。
  • 批准号:
    10829529
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
National Ecological Observatory Network Governing Cooperative Agreement
国家生态观测站网络治理合作协议
  • 批准号:
    2346114
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
    Cooperative Agreement
The Kansas Department of Agriculture's Flexible Funding Model Cooperative Agreement for MFRPS Maintenance, FPTF, and Special Project.
堪萨斯州农业部针对 MFRPS 维护、FPTF 和特别项目的灵活资助模式合作协议。
  • 批准号:
    10828588
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
Robust approaches for the analysis of agreement between clinical measurements: development of guidance and software tools for researchers
分析临床测量之间一致性的稳健方法:为研究人员开发指南和软件工具
  • 批准号:
    MR/X029301/1
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
    Research Grant
Doctoral Dissertation Research: Linguistic transfer in a contact variety of Spanish: Gender agreement production and attitudes
博士论文研究:西班牙语接触变体中的语言迁移:性别协议的产生和态度
  • 批准号:
    2234506
  • 财政年份:
    2023
  • 资助金额:
    $ 72.78万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了